These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28123441)

  • 1. Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility.
    Kamfar S; Alavian SM; Houshmand M; Yadegarazari R; Seifi Zarei B; Khalaj A; Shabab N; Saidijam M
    Hepat Mon; 2016 Dec; 16(12):e40774. PubMed ID: 28123441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease.
    Malik AN; Simões ICM; Rosa HS; Khan S; Karkucinska-Wieckowska A; Wieckowski MR
    Cells; 2019 Oct; 8(10):. PubMed ID: 31597406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood mononuclear cell mitochondrial copy number and adenosine triphosphate inhibition test in NAFLD.
    Lee AH; Oh JH; Kim HS; Shin JH; Yoon EL; Jun DW
    Front Endocrinol (Lausanne); 2022; 13():967848. PubMed ID: 36353244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial genome architecture in non-alcoholic fatty liver disease.
    Sookoian S; Flichman D; Scian R; Rohr C; Dopazo H; Gianotti TF; Martino JS; Castaño GO; Pirola CJ
    J Pathol; 2016 Dec; 240(4):437-449. PubMed ID: 27577682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial DNA 4977-bp deletion and copy number alteration in Han Chinese samples with uterine fibroids.
    Luo Y; Zou Y; Wu J; Zhang ZY; Liu FY; Li LP; Huang OP
    Ann Hum Genet; 2019 Jul; 83(4):220-230. PubMed ID: 30821350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.
    Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW
    Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of mitochondrial DNA deletion and copy number variations on different exercise intensities in highly trained swimmers.
    Baykara O; Sahin SK; Akbas F; Guven M; Onaran I
    Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):109-115. PubMed ID: 27894409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
    Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
    World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Leukocyte Mitochondrial DNA Copy Number and Non-alcoholic Fatty Liver Disease in a Chinese Population Is Mediated by 8-Oxo-2'-Deoxyguanosine.
    Ma C; Liu Y; He S; Zeng J; Li P; Ma C; Ping F; Zhang H; Xu L; Li W; Li Y
    Front Med (Lausanne); 2020; 7():536. PubMed ID: 33015093
    [No Abstract]   [Full Text] [Related]  

  • 12. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease.
    Pirola CJ; Gianotti TF; Burgueño AL; Rey-Funes M; Loidl CF; Mallardi P; Martino JS; Castaño GO; Sookoian S
    Gut; 2013 Sep; 62(9):1356-63. PubMed ID: 22879518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum homocysteine levels in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Patsiaoura K; Katsiki E; Zafeiriadou E; Deretzi G; Zavos C; Gavalas E; Katsinelos P; Mane V; Slavakis A
    Ann Hepatol; 2012; 11(1):68-76. PubMed ID: 22166563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver.
    Jamwal R; de la Monte SM; Ogasawara K; Adusumalli S; Barlock BB; Akhlaghi F
    Mol Pharm; 2018 Jul; 15(7):2621-2632. PubMed ID: 29792708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
    Del Chierico F; Nobili V; Vernocchi P; Russo A; De Stefanis C; Gnani D; Furlanello C; Zandonà A; Paci P; Capuani G; Dallapiccola B; Miccheli A; Alisi A; Putignani L
    Hepatology; 2017 Feb; 65(2):451-464. PubMed ID: 27028797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis of mitochondrial DNA in Fuchs endothelial corneal dystrophy.
    Czarny P; Seda A; Wielgorski M; Binczyk E; Markiewicz B; Kasprzak E; Jiménez-García MP; Grabska-Liberek I; Pawlowska E; Blasiak J; Szaflik J; Szaflik JP
    Mutat Res; 2014 Feb; 760():42-7. PubMed ID: 24374226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency.
    Sookoian S; Puri P; Castaño GO; Scian R; Mirshahi F; Sanyal AJ; Pirola CJ
    Liver Int; 2017 Apr; 37(4):611-619. PubMed ID: 27614103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.
    Aida Y; Abe H; Tomita Y; Nagano T; Seki N; Sugita T; Itagaki M; Ishiguro H; Sutoh S; Aizawa Y
    Int J Clin Exp Med; 2014; 7(11):4191-8. PubMed ID: 25550930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Lee C; Kim J; Jung Y
    Cells; 2019 Oct; 8(10):. PubMed ID: 31619023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.